PVI
Pura Vida Investments’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Hold |
0
| – | – | – | 67 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 126 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 134 |
|
|
2022
Q2 | – | Sell |
-132,571
| Closed | -$4.52M | – | 135 |
|
|
2022
Q1 | $4.52M | Buy |
132,571
+800
| +0.6% | +$27.2K | 0.15% | 45 |
|
|
2021
Q4 | $5.09M | Buy |
131,771
+54,486
| +71% | +$2.11M | 0.18% | 46 |
|
|
2021
Q3 | $4.17M | Sell |
77,285
-27,771
| -26% | -$1.5M | 0.13% | 79 |
|
|
2021
Q2 | $3.51M | Sell |
105,056
-58,559
| -36% | -$1.96M | 0.11% | 82 |
|
|
2021
Q1 | $3.37M | Buy |
+163,615
| New | +$3.37M | 0.1% | 90 |
|
|
2020
Q4 | – | Sell |
-144,200
| Closed | -$2.14M | – | 128 |
|
|
2020
Q3 | $2.14M | Sell |
144,200
-105,900
| -42% | -$1.57M | 0.11% | 70 |
|
|
2020
Q2 | $3.25M | Buy |
+250,100
| New | +$3.25M | 0.31% | 47 |
|